Skip to content
beroni logo newberoni logo new
  • About
    • About Beroni
    • Our History
    • Board of Directors
    • Management Team
    • Vision, Mission and Values
  • R&D
  • Core Businesses
    • Cell Therapies
    • Anti-Cancer Drugs
    • Infectious Diseases
    • Infectious Diseases – COVID-19
    • E-commerce
  • Products
    • By Beroni China
    • By Beroni USA
    • By Beroni Biotech
  • Investors
    • Announcements
    • Financial Information
    • Corporate Governance
    • Stock Information
    • Globenewswire Press Releases
    • Medtech Outlook
    • Research Report
    • COVID-19 Vaccines Overview
    • FAQs
  • News
  • Contact
  • English
    • 简体中文
Menu Close
  1. Home>
  2. 2017>
  3. December>
  4. 19>
  5. 2017>
  6. Congratulate Beroni Group on becoming the member of CRCNA officially, aiming to promote the undertaking of Northern Australia Development Project
You are currently viewing Congratulate Beroni Group on  becoming the member of CRCNA officially, aiming to promote the undertaking of Northern Australia Development Project

Congratulate Beroni Group on becoming the member of CRCNA officially, aiming to promote the undertaking of Northern Australia Development Project

  • Post author:admin
  • Post published:2017-12-19
  • Post category:2017

Congratulate Beroni Group on  becoming the member of CRCNA officially, aiming to promote the undertaking of Northern Australia Development Project

You Might Also Like

Read more about the article Beroni Group establishing a strategic partnership with the University of New South Wales

Beroni Group establishing a strategic partnership with the University of New South Wales

2017-06-09
Read more about the article Beroni Group cooperated with DENDRIX

Beroni Group cooperated with DENDRIX

2017-10-30
Read more about the article Non-Executive Director of Beroni Group: Peter Came to Beroni Group Conducting a Legal Compliance Training

Non-Executive Director of Beroni Group: Peter Came to Beroni Group Conducting a Legal Compliance Training

2017-04-08

Search Article

Arrange by Year

  • 2017 (10)
  • 2018 (24)
  • 2019 (25)
  • 2020 (17)
  • 2021 (11)
  • 2022 (8)
  • 2023 (2)

What’s New

  • Beroni and Shenyang University Of Chemical Technology Successfully Signed the Practice Base Agreement
  • Beroni Group Advances Research and Development of its Enhanced COVID-19 Antigen Rapid Test Kit
  • Wish You Happy New Year!
  • Beroni Pharmaceutical (Guangdong) Co., Ltd. Won the 3rd Prize of the Enterprise Group of Jingniuhui “Biomedical and Medical Devices” with the Innovative Drug for Advanced Solid Tumor Project
  • Beroni Group Attending the Third TMU Pharmaceutical Forum and Annual Meeting of Pharmaceutical Branch of China National Health Association

Beroni Group is an international biotechnological company listed on the National Stock Exchange (Australia) and traded on the OTC markets in the USA with business presence in Australia, China, Japan and the USA. It currently has four core businesses – research and development of new drugs and clinical trial, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.

About

  • About Beroni
  • Our History
  • Board of Directors
  • Management Team
  • Vision, Mission, and Values

Core Businesses

  • Cell Therapy
  • Anti-Cancer Drugs
  • Infectious Diseases
  • E-Commerce

Products

  • By Beroni China
  • By Beroni Japan
  • By Beroni USA

Copyrights© Beroni Group 2019 | All rights reserved |

website by chase e-Design

Close Menu